Carl J. Fichtenbaum, MD

Abidi, Maheen Z; Umbleja, Triin; Overton, Edgar T; Burdo, Tricia; Flynn, Jacqueline M; Lu, Michael T; Taron, Jana; Schnittman, Samuel R; Fitch, Kathleen V; Zanni, Markella V; Fichtenbaum, Carl J; Malvestutto, Carlos; Aberg, Judith A; Fulda, Evelynne S; Eckard, Allison Ross; Manne-Goehler, Jennifer; Tuan, Jessica J; Ribaudo, Heather J; Douglas, Pamela S; Grinspoon, Steven K; Brown, Todd T; Erlandson, Kristine M 2024. CMV IgG is Associated with Physical Function but not Muscle Density in People with HIV. Journal of acquired immune deficiency syndromes (1999), ,

Bhattacharya, Romit; Uddin, Md Mesbah; Patel, Aniruddh P; Niroula, Abhishek; Finneran, Phoebe; Bernardo, Rachel; Fitch, Kathleen V; Lu, Michael T; Bloomfield, Gerald S; Malvestutto, Carlos; Aberg, Judy A; Fichtenbaum, Carl J; Hornsby, Whitney; Ribaudo, Heather J; Libby, Peter; Ebert, Benjamin L; Zanni, Markella V; Douglas, Pamela S; Grinspoon, Steven K; Natarajan, Pradeep 2024. Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances, 8 4, 959-967

Lu, Michael T; Ribaudo, Heather; Foldyna, Borek; Zanni, Markella V; Mayrhofer, Thomas; Karady, Julia; Taron, Jana; Fitch, Kathleen V; McCallum, Sara; Burdo, Tricia H; Paradis, Kayla; Hedgire, Sandeep S; Meyersohn, Nandini M; DeFilippi, Christopher; Malvestutto, Carlos D; Sturniolo, Audra; Diggs, Marissa; Siminski, Sue; Bloomfield, Gerald S; Alston-Smith, Beverly; Desvigne-Nickens, Patrice; Overton, Edgar T; Currier, Judith S; Aberg, Judith A; Fichtenbaum, Carl J; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K 2024. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial. JAMA cardiology, ,

Orkin, Chloe; Molina, Jean-Michel; Cahn, Pedro; Lombaard, Johannes; Supparatpinyo, Khuanchai; Kumar, Sushma; Campbell, Havilland; Wan, Hong; Teal, Valerie; Jin Xu, Zhi; Asante-Appiah, Ernest; Sklar, Peter; Teppler, Hedy; Lahoulou, Rima 2024. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials. The lancet. HIV, 11 2, e75-e85

Atehortua, Laura; Baig, Mirza; Morris, Jamie; Trentman, Sarah; Davidson, W Sean; Fichtenbaum, Carl J; Chougnet, Claire A 2023. Impaired response of memory Treg to high density lipoproteins is associated with intermediate/high cardiovascular disease risk in persons with HIV. Frontiers in immunology, 14 , 1146624

Douglas, Pamela S; McCallum, Sara; Lu, Michael T; Umbleja, Triin; Fitch, Kathleen V; Foldyna, Borek; Zanni, Markella V; Fulda, Evelynne S; Bloomfield, Gerald S; Fichtenbaum, Carl J; Overton, Edgar T; Aberg, Judith A; Malvestutto, Carlos D; Burdo, Tricia H; Arduino, Roberto C; Ho, Ken S; Yin, Michael T; Ribaudo, Heather J; Grinspoon, Steven K 2023. Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV. AIDS (London, England), 37 3, 423-434

Erlandson, Kristine M; Umbleja, Triin; Lu, Michael T; Taron, Jana; Ribaudo, Heather J; Overton, Edgar T; Presti, Rachel M; Haas, David W; Sax, Paul E; Yin, Michael T; Zhai, Bingxue Kris; Louis, Rochelle; Upadhyay, Namrata; Eslami, Parastou; Douglas, Pamela S; Zanni, Markella V; Fitch, Kathleen V; Fulda, Evelynne S; Fichtenbaum, Carl J; Malvestutto, Carlos D; Grinspoon, Steven K; Brown, Todd T 2023. Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function. Journal of acquired immune deficiency syndromes (1999), 94 2, 174-184

Evering, Teresa H; Chew, Kara W; Giganti, Mark J; Moser, Carlee; Pinilla, Mauricio; Wohl, David Alain; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Bender Ignacio, Rachel; Margolis, David; Zhu, Qing; Ma, Ji; Zhong, Lijie; Yan, Li; D'Andrea Nores, Ulises; Hoover, Keila; Mocherla, Bharat; Choudhary, Manish C; Deo, Rinki; Ritz, Justin; Fischer, William A; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Daar, Eric S 2023. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Annals of internal medicine, 176 5, 658-666

Fichtenbaum, Carl J; Mallon, Patrick 2023. Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled? AIDS (London, England), 37 3, 541-543

Foldyna, Borek; Mayrhofer, Thomas; Zanni, Markella V; Lyass, Asya; Barve, Radhika; Karady, Julia; McCallum, Sara; Burdo, Tricia H; Fitch, Kathleen V; Paradis, Kayla; Fulda, Evelynne S; Diggs, Marissa R; Bloomfield, Gerald S; Malvestutto, Carlos D; Fichtenbaum, Carl J; Aberg, Judith A; Currier, Judith S; Ribaudo, Heather J; Hoffmann, Udo; Lu, Michael T; Douglas, Pamela S; Grinspoon, Steven K 2023. Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 77 12, 1676-1686

Fulda, Evelynne S; Fichtenbaum, Carl J; Kileel, Emma M; Zanni, Markella V; Aberg, Judith A; Malvestutto, Carlos; Cardoso, Sandra Wagner; Berzins, Baiba; Lira, Rita; Harden, Regina; Robbins, Gregory; Martinez, Maria; Nieves, Sylvia Davila; McCallum, Sara; Cruz, Jorge Leon; Umbleja, Triin; Sprenger, Heather; Giguel, Francoise; Bone, Frederic; Wood, Ken; Byroads, Mark; Paradis, Kayla; Lu, Michael T; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K; Fitch, Kathleen V 2023. The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial. Contemporary clinical trials, 124 , 107035

Grinspoon, Steven K; Fitch, Kathleen V; Zanni, Markella V; Fichtenbaum, Carl J; Umbleja, Triin; Aberg, Judith A; Overton, Edgar T; Malvestutto, Carlos D; Bloomfield, Gerald S; Currier, Judith S; Martinez, Esteban; Roa, Jhoanna C; Diggs, Marissa R; Fulda, Evelynne S; Paradis, Kayla; Wiviott, Stephen D; Foldyna, Borek; Looby, Sara E; Desvigne-Nickens, Patrice; Alston-Smith, Beverly; Leon-Cruz, Jorge; McCallum, Sara; Hoffmann, Udo; Lu, Michael T; Ribaudo, Heather J; Douglas, Pamela S 2023. Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. The New England journal of medicine, 389 8, 687-699

Haworth, Kevin J; Niederhausen, Kelly C; Smith, Eric P; Sadayappan, Sakthivel; Wess, Yolanda; Rubinstein, Jack; Schauer, Daniel P; Soleimani, Manoocher; Rouan, Gregory W; Fichtenbaum, Carl J 2023. Research Initiative Supporting Excellence at the University of Cincinnati (RISE-UC): A Program to Develop and Support Research-Active Faculty Members. Academic medicine : journal of the Association of American Medical Colleges, 98 10, 1120-1130

Kileel, Emma M; Malvestutto, Carlos D; Lo, Janet; Fitch, Kathleen V; Fichtenbaum, Carl J; Aberg, Judith A; Zanni, Markella V; Martinez, Esteban; Okeke, Nwora Lance; Kumar, Princy; Joao, Esau; Bares, Sara H; Berrner, Daniel; Smieja, Marek; Roa, Jhoanna C; McCallum, Sara; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K 2023. Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76 11, 2010-2013

Kolossváry, Márton; deFilippi, Chris; McCallum, Sara; Fitch, Kathleen V; Diggs, Marissa R; Fulda, Evelynne S; Ribaudo, Heather J; Fichtenbaum, Carl J; Aberg, Judith A; Malvestutto, Carlos D; Currier, Judith S; Casado, Jose L; Gutiérrez, Félix; Sereti, Irini; Douglas, Pamela S; Zanni, Markella V; Grinspoon, Steven K 2023. Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV. EBioMedicine, 90 , 104538

Lake, Jordan E; Taron, Jana; Ribaudo, Heather J; Leon-Cruz, Jorge; Utay, Netanya S; Swaminathan, Shobha; Fitch, Kathleen V; Kileel, Emma M; Paradis, Kayla; Fulda, Evelynne S; Ho, Ken S; Luetkemeyer, Anne F; Johnston, Carrie D; Zanni, Markella V; Douglas, Pamela S; Grinspoon, Steven K; Lu, Michael T; Fichtenbaum, Carl J 2023. Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV. AIDS (London, England), 37 14, 2149-2159

Marzinke, Mark A; Hanscom, Brett; Wang, Zhe; Safren, Steven A; Psaros, Christina; Donnell, Deborah; Richardson, Paul A; Sullivan, Philip; Eshleman, Susan H; Jennings, Andrea; Feliciano, Kailazarid Gomez; Jalil, Emilia; Coutinho, Carolina; Cardozo, Nadir; Maia, Bernardo; Khan, Taimur; Singh, Yashna; Middelkoop, Keren; Franks, Julie; Valencia, Javier; Sanchez, Naiymah; Lucas, Jonathan; Rooney, James F; Rinehart, Alex R; Ford, Susan; Adeyeye, Adeola; Cohen, Myron S; McCauley, Marybeth; Landovitz, Raphael J; Grinsztejn, Beatriz 2023. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial. The lancet. HIV, 10 11, e703-e712

Mena Lora, Alfredo J; Long, Jessica E; Huang, Yunda; Baden, Lindsey R; El Sahly, Hana M; Follmann, Dean; Goepfert, Paul; Gray, Glenda; Grinsztejn, Beatriz; Kotloff, Karen; Rouphael, Nadine; Sobieszczyk, Magdelena; Walsh, Stephen R; Andriesen, Jessica; Shah, Karan A; Zhang, Yuanyuan; Gilbert, Peter; Janes, Holly; Gay, Cynthia L; Falsey, Ann R; Tripp, Rebecca L; Gorman, Richard L; Tong, Tina; Marovich, Mary; Neuzil, Kathleen; Corey, Lawrence; Kublin, James G 2023. Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. JAMA network open, 6 1, e2251974

Rick, Anne-Marie; Laurens, Matthew B; Huang, Ying; Yu, Chenchen; Martin, Thomas C S; Rodriguez, Carina A; Rostad, Christina A; Maboa, Rebone M; Baden, Lindsey R; El Sahly, Hana M; Grinsztejn, Beatriz; Gray, Glenda E; Gay, Cynthia L; Gilbert, Peter B; Janes, Holly E; Kublin, James G; Huang, Yunda; Leav, Brett; Hirsch, Ian; Struyf, Frank; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Goepfert, Paul A; Walsh, Stephen R; Follmann, Dean; Kotloff, Karen L 2023. Risk of COVID-19 after natural infection or vaccination. EBioMedicine, 96 , 104799

Schnittman, Samuel R; Jung, Wonyeong; Fitch, Kathleen V; Zanni, Markella V; McCallum, Sara; Lee, Jessica Shih-Lu; Shin, Sally; Davis, Brandon J; Fulda, Evelynne S; Diggs, Marissa R; Giguel, Francoise; Chinchay, Romina; Sheth, Anandi N; Fichtenbaum, Carl J; Malvestutto, Carlos; Aberg, Judith A; Currier, Judith; Lauffenburger, Douglas A; Douglas, Pamela S; Ribaudo, Heather J; Alter, Galit; Grinspoon, Steven K 2023. Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV. JCI insight, 8 5,

Schnittman, Samuel R; Kitch, Douglas W; Swartz, Talia H; Burdo, Tricia H; Fitch, Kathleen V; McCallum, Sara; Flynn, Jacqueline M; Fulda, Evelynne S; Diggs, Marissa R; Stapleton, Jack T; Casado, José L; Taron, Jana; Currier, Judith S; Zanni, Markella V; Malvestutto, Carlos; Fichtenbaum, Carl J; Aberg, Judith A; Ribaudo, Heather J; Lu, Michael T; Douglas, Pamela S; Grinspoon, Steven K 2023. Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus. Open forum infectious diseases, 10 3, ofad106

Schnittman, Samuel R; Kolossváry, Márton; Beck-Engeser, Gabriele; Fitch, Kathleen V; Ambayec, Gabrielle C; Nance, Robin M; Zanni, Markella V; Diggs, Marissa; Chan, Fay; McCallum, Sara; Toribio, Mabel; Bamford, Laura; Fichtenbaum, Carl J; Eron, Joseph J; Jacobson, Jeffrey M; Mayer, Kenneth H; Malvestutto, Carlos; Bloomfield, Gerald S; Moore, Richard D; Umbleja, Triin; Saag, Michael S; Aberg, Judith A; Currier, Judith S; Delaney, Joseph A C; Martin, Jeffrey N; Lu, Michael T; Douglas, Pamela S; Ribaudo, Heather J; Crane, Heidi M; Hunt, Peter W; Grinspoon, Steven K 2023. Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus. Open forum infectious diseases, 10 10, ofad467

Schnittman, Samuel R; Lu, Michael T; Mayrhofer, Thomas; Burdo, Tricia H; Fitch, Kathleen V; McCallum, Sara; Fulda, Evelynne S; Zanni, Markella V; Foldyna, Borek; Malvestutto, Carlos; Fichtenbaum, Carl J; Aberg, Judith A; Bloomfield, Gerald S; Overton, Edgar T; Currier, Judith; Tebas, Pablo; Sha, Beverly E; Ribaudo, Heather J; Flynn, Jacqueline M; Douglas, Pamela S; Erlandson, Kristine M; Grinspoon, Steven K 2023. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76 3, e613-e621

Theodore, Deborah A; Branche, Angela R; Zhang, Lily; Graciaa, Daniel S; Choudhary, Madhu; Hatlen, Timothy J; Osman, Raadhiya; Babu, Tara M; Robinson, Samuel T; Gilbert, Peter B; Follmann, Dean; Janes, Holly; Kublin, James G; Baden, Lindsey R; Goepfert, Paul; Gray, Glenda E; Grinsztejn, Beatriz; Kotloff, Karen L; Gay, Cynthia L; Leav, Brett; Miller, Jacqueline; Hirsch, Ian; Sadoff, Jerald; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Falsey, Ann R; El Sahly, Hana M; Sobieszczyk, Magdalena E; Huang, Yunda 2023. Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. JAMA network open, 6 7, e2323349

Zanni, Markella V; Foldyna, Borek; McCallum, Sara; Burdo, Tricia H; Looby, Sara E; Fitch, Kathleen V; Fulda, Evelynne S; Autissier, Patrick; Bloomfield, Gerald S; Malvestutto, Carlos D; Fichtenbaum, Carl J; Overton, Edgar T; Aberg, Judith A; Erlandson, Kristine M; Campbell, Thomas B; Ellsworth, Grant B; Sheth, Anandi N; Taiwo, Babafemi; Currier, Judith S; Hoffmann, Udo; Lu, Michael T; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K 2023. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76 2, 323-334

Bloomfield, Gerald S; Weir, Isabelle R; Ribaudo, Heather J; Fitch, Kathleen V; Fichtenbaum, Carl J; Moran, Laura E; Bedimo, Roger; de Filippi, Christopher; Morse, Caryn G; Piccini, Jonathan; Zanni, Markella V; Lu, Michael T; Hoffmann, Udo; Grinspoon, Steven K; Douglas, Pamela S 2022. Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Journal of acquired immune deficiency syndromes (1999), 89 3, 349-359

Erlandson, Kristine M; Fitch, Kathleen V; McCallum, Sara A; Ribaudo, Heather J; Overton, Edgar T; Zanni, Markella V; Bloomfield, Gerald S; Brown, Todd T; Fichtenbaum, Carl J; Bares, Sara; Aberg, Judith A; Douglas, Pamela S; Fulda, Evelynne S; Santana-Bagur, Jorge L; Castro, Jose G; Moran, Laura E; Mave, Vidya; Supparatpinyo, Khuanchai; Ponatshego, Ponego L; Schechter, Mauro; Grinspoon, Steven K 2022. Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75 7, 1154-1163

Feria, Manuel G; Chang, Cecilia; Ticona, Eduardo; Moussa, Anissa; Zhang, Bin; Ballena, Isabel; Azañero, Ruben; Ticona, Cesar; De Cecco, Carlo N; Fichtenbaum, Carl J; O'Donnell, Robert E; La Rosa, Alberto; Sanchez, Jorge; Andorf, Sandra; Atehortua, Laura; Katz, Jonathan D; Chougnet, Claire A; Deepe, George S; Huaman, Moises A 2022. Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection. Open forum infectious diseases, 9 12, ofac629

Fitch, Kathleen V; McCallum, Sara A; Erlandson, Kristine M; Overton, Edgar Turner; Zanni, Markella V; Fichtenbaum, Carl; Aberg, Judith A; Fulda, Evelynne S; Kileel, Emma M; Moran, Laura E; Bloomfield, Gerald S; Novak, Richard M; Pérez-Frontera, Sigrid; Abrams-Downey, Alexandra; Pierone, Gerald; Kumarasamy, Nagalingeswaran; Ruxrungtham, Kiat; Mngqibisa, Rosie; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K 2022. Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk. AIDS (London, England), 36 14, 1997-2003

Fulda, Evelynne S; Fitch, Kathleen V; Overton, Edgar T; Zanni, Markella V; Aberg, Judith A; Currier, Judith S; Lu, Michael T; Malvestutto, Carlos; Fichtenbaum, Carl J; Martinez, Esteban; Umbleja, Triin; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K 2022. COVID-19 Vaccination Rates in a Global HIV Cohort. The Journal of infectious diseases, 225 4, 603-607

Guanira, Juan V; Fichtenbaum, Carl J 2022. Is it time to retire efavirenz as a first-line option worldwide? AIDS (London, England), 36 2, 317-318

Hagey, Rachel J; Elazar, Menashe; Pham, Edward A; Tian, Siqi; Ben-Avi, Lily; Bernardin-Souibgui, Claire; Yee, Matthew F; Moreira, Fernando R; Rabinovitch, Meirav Vilan; Meganck, Rita M; Fram, Benjamin; Beck, Aimee; Gibson, Scott A; Lam, Grace; Devera, Josephine; Kladwang, Wipapat; Nguyen, Khanh; Xiong, Anming; Schaffert, Steven; Avisar, Talia; Liu, Ping; Rustagi, Arjun; Fichtenbaum, Carl J; Pang, Phillip S; Khatri, Purvesh; Tseng, Chien-Te; Taubenberger, Jeffery K; Blish, Catherine A; Hurst, Brett L; Sheahan, Timothy P; Das, Rhiju; Glenn, Jeffrey S 2022. Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2. Nature medicine, 28 9, 1944-1955

Kolossváry, Márton; deFilippi, Chris; Lu, Michael T; Zanni, Markella V; Fulda, Evelynne S; Foldyna, Borek; Ribaudo, Heather; Mayrhofer, Thomas; Collier, Ann C; Bloomfield, Gerald S; Fichtenbaum, Carl; Overton, Edgar T; Aberg, Judith A; Currier, Judith; Fitch, Kathleen V; Douglas, Pamela S; Grinspoon, Steven K 2022. Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy. The Journal of infectious diseases, 226 10, 1809-1822

Looby, Sara E; Kantor, Amy; Burdo, Tricia H; Currier, Judith S; Fichtenbaum, Carl J; Overton, Edgar T; Aberg, Judith A; Malvestutto, Carlos D; Bloomfield, Gerald S; Erlandson, Kristine M; Cespedes, Michelle; Kallas, Esper G; Masiá, Mar; Thornton, Alice C; Smith, Mandy D; Flynn, Jacqueline M; Kileel, Emma M; Fulda, Evelynne; Fitch, Kathleen V; Lu, Michael T; Douglas, Pamela S; Grinspoon, Steven K; Ribaudo, Heather J; Zanni, Markella V 2022. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75 8, 1324-1333

O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Musser, Bret J; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Brown, Elizabeth R; Heirman, Ingeborg; Davis, John D; Turner, Kenneth C; Ramesh, Divya; Mahmood, Adnan; Hooper, Andrea T; Hamilton, Jennifer D; Kim, Yunji; Purcell, Lisa A; Baum, Alina; Kyratsous, Christos A; Krainson, James; Perez-Perez, Richard; Mohseni, Rizwana; Kowal, Bari; DiCioccio, A Thomas; Geba, Gregory P; Stahl, Neil; Lipsich, Leah; Braunstein, Ned; Herman, Gary; Yancopoulos, George D; Weinreich, David M 2022. Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial. JAMA, 327 5, 432-441

Overton, Edgar T; Weir, Isabelle R; Zanni, Markella V; Fischinger, Stephanie; MacArthur, Rodger D; Aberg, Judith A; Fitch, Kathleen V; Frank, Michael; Albrecht, Helmut; Goodenough, Elliot; Rhame, Frank S; Fichtenbaum, Carl J; Bloomfield, Gerald S; Malvestutto, Carlos; Supparatpinyo, Khuanchai; McCallum, Sara; Douglas, Pamela S; Alter, Galit; Ribaudo, Heather; Grinspoon, Steven K 2022. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV. Journal of acquired immune deficiency syndromes (1999), 90 4, 377-381

Baden, Lindsey R; El Sahly, Hana M; Essink, Brandon; Kotloff, Karen; Frey, Sharon; Novak, Rick; Diemert, David; Spector, Stephen A; Rouphael, Nadine; Creech, C Buddy; McGettigan, John; Khetan, Shishir; Segall, Nathan; Solis, Joel; Brosz, Adam; Fierro, Carlos; Schwartz, Howard; Neuzil, Kathleen; Corey, Larry; Gilbert, Peter; Janes, Holly; Follmann, Dean; Marovich, Mary; Mascola, John; Polakowski, Laura; Ledgerwood, Julie; Graham, Barney S; Bennett, Hamilton; Pajon, Rolando; Knightly, Conor; Leav, Brett; Deng, Weiping; Zhou, Honghong; Han, Shu; Ivarsson, Melanie; Miller, Jacqueline; Zaks, Tal 2021. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. The New England journal of medicine, 384 5, 403-416

Cohen, Myron S; Nirula, Ajay; Mulligan, Mark J; Novak, Richard M; Marovich, Mary; Yen, Catherine; Stemer, Alexander; Mayer, Stockton M; Wohl, David; Brengle, Blair; Montague, Brian T; Frank, Ian; McCulloh, Russell J; Fichtenbaum, Carl J; Lipson, Brad; Gabra, Nashwa; Ramirez, Julio A; Thai, Christine; Chege, Wairimu; Gomez Lorenzo, Margarita M; Sista, Nirupama; Farrior, Jennifer; Clement, Meredith E; Brown, Elizabeth R; Custer, Kenneth L; Van Naarden, Jacob; Adams, Andrew C; Schade, Andrew E; Dabora, Matan C; Knorr, Jack; Price, Karen L; Sabo, Janelle; Tuttle, Jay L; Klekotka, Paul; Shen, Lei; Skovronsky, Daniel M 2021. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. JAMA, 326 1, 46-55

Douglas, Pamela S; Umbleja, Triin; Bloomfield, Gerald S; Fichtenbaum, Carl J; Zanni, Markella V; Overton, Edgar T; Fitch, Kathleen V; Kileel, Emma M; Aberg, Judith A; Currier, Judith; Sponseller, Craig A; Melbourne, Kathleen; Avihingsanon, Anchalee; Bustorff, Flavio; Estrada, Vicente; Ruxrungtham, Kiat; Saumoy, Maria; Navar, Ann Marie; Hoffmann, Udo; Ribaudo, Heather J; Grinspoon, Steven 2021. Cardiovascular Risk and Health Among People With HIV Eligible for Primary Prevention: Insights From the REPRIEVE Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

El Sahly, Hana M; Baden, Lindsey R; Essink, Brandon; Doblecki-Lewis, Susanne; Martin, Judith M; Anderson, Evan J; Campbell, Thomas B; Clark, Jesse; Jackson, Lisa A; Fichtenbaum, Carl J; Zervos, Marcus; Rankin, Bruce; Eder, Frank; Feldman, Gregory; Kennelly, Christina; Han-Conrad, Laurie; Levin, Michael; Neuzil, Kathleen M; Corey, Lawrence; Gilbert, Peter; Janes, Holly; Follmann, Dean; Marovich, Mary; Polakowski, Laura; Mascola, John R; Ledgerwood, Julie E; Graham, Barney S; August, Allison; Clouting, Heather; Deng, Weiping; Han, Shu; Leav, Brett; Manzo, Deb; Pajon, Rolando; Schödel, Florian; Tomassini, Joanne E; Zhou, Honghong; Miller, Jacqueline 2021. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. The New England journal of medicine, 385 19, 1774-1785

Fichtenbaum, Carl J; Ribaudo, Heather J; Leon-Cruz, Jorge; Overton, Edgar T; Zanni, Markella V; Malvestutto, Carlos D; Aberg, Judith A; Kileel, Emma M; Fitch, Kathleen V; Van Schalkwyk, Marije; Kumarasamy, Nagalingeswaran; Martinez, Esteban; Santos, Breno Riegel; Joseph, Yvetot; Lo, Janet; Siminski, Sue; Melbourne, Kathleen; Sponseller, Craig A; Desvigne-Nickens, Patrice; Bloomfield, Gerald S; Currier, Judith S; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K 2021. Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. The Journal of infectious diseases, 223 2, 352

Haukoos, Jason S; Lyons, Michael S; Rothman, Richard E; White, Douglas A E; Hopkins, Emily; Bucossi, Meggan; Ruffner, Andrew H; Ancona, Rachel M; Hsieh, Yu-Hsiang; Peterson, Stephen C; Signer, Danielle; Toerper, Matthew F; Saheed, Mustapha; Pfeil, Sarah K; Todorovic, Tamara; Al-Tayyib, Alia A; Bradley-Springer, Lucy; Campbell, Jonathan D; Gardner, Edward M; Rowan, Sarah E; Sabel, Allison L; Thrun, Mark W 2021. Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial. JAMA network open, 4 7, e2117763

Hoffmann, Udo; Lu, Michael T; Foldyna, Borek; Zanni, Markella V; Karady, Julia; Taron, Jana; Zhai, Bingxue K; Burdo, Tricia; Fitch, Kathleen V; Kileel, Emma M; Williams, Kenneth; Fichtenbaum, Carl J; Overton, Edgar T; Malvestutto, Carlos; Aberg, Judith; Currier, Judith; Sponseller, Craig A; Melbourne, Kathleen; Floris-Moore, Michelle; Van Dam, Cornelius; Keefer, Michael C; Koletar, Susan L; Douglas, Pamela S; Ribaudo, Heather; Mayrhofer, Thomas; Grinspoon, Steven K 2021. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA network open, 4 6, e2114923

Huaman, Moises A; De Cecco, Carlo N; Bittencourt, Marcio S; Ticona, Eduardo; Kityo, Cissy; Ballena, Isabel; Nalukwago, Sophie; Nazzinda, Rashidah; Ticona, Cesar; Azañero, Ruben; Zhang, Bin; Farquhar, Carey; Hawn, Thomas R; Sterling, Timothy R; Fichtenbaum, Carl J; Longenecker, Chris T 2021. Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Huaman, Moises A; Fichtenbaum, Carl J 2021. Bearing the Burden of Non-AIDS Comorbidities: This Is What Women Aging With Human Immunodefiency Virus Look Like. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72 8, 1312-1313

Huaman, Moises A; Juchnowski, Steven M; Zidar, David A; Kityo, Cissy M; Nalukwago, Sophie; Nazzinda, Rashidah; Fichtenbaum, Carl J; Longenecker, Chris T 2021. Monocyte activation in persons living with HIV and tuberculosis coinfection. AIDS (London, England), 35 3, 447-452

Kileel, Emma M; Lo, Janet; Malvestutto, Carlos; Fitch, Kathleen V; Zanni, Markella V; Fichtenbaum, Carl J; Overton, Edgar T; Okeke, Nwora Lance; Kumar, Princy; Joao, Esau; Aberg, Judith A; Martinez, Esteban; Currier, Judith S; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K 2021. Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open forum infectious diseases, 8 12, ofab537

Landovitz, Raphael J; Donnell, Deborah; Clement, Meredith E; Hanscom, Brett; Cottle, Leslie; Coelho, Lara; Cabello, Robinson; Chariyalertsak, Suwat; Dunne, Eileen F; Frank, Ian; Gallardo-Cartagena, Jorge A; Gaur, Aditya H; Gonzales, Pedro; Tran, Ha V; Hinojosa, Juan C; Kallas, Esper G; Kelley, Colleen F; Losso, Marcelo H; Madruga, J Valdez; Middelkoop, Keren; Phanuphak, Nittaya; Santos, Breno; Sued, Omar; Valencia Huamaní, Javier; Overton, Edgar T; Swaminathan, Shobha; Del Rio, Carlos; Gulick, Roy M; Richardson, Paul; Sullivan, Philip; Piwowar-Manning, Estelle; Marzinke, Mark; Hendrix, Craig; Li, Maoji; Wang, Zhe; Marrazzo, Jeanne; Daar, Eric; Asmelash, Aida; Brown, Todd T; Anderson, Peter; Eshleman, Susan H; Bryan, Marcus; Blanchette, Cheryl; Lucas, Jonathan; Psaros, Christina; Safren, Steven; Sugarman, Jeremy; Scott, Hyman; Eron, Joseph J; Fields, Sheldon D; Sista, Nirupama D; Gomez-Feliciano, Kailazarid; Jennings, Andrea; Kofron, Ryan M; Holtz, Timothy H; Shin, Katherine; Rooney, James F; Smith, Kimberly Y; Spreen, William; Margolis, David; Rinehart, Alex; Adeyeye, Adeola; Cohen, Myron S; McCauley, Marybeth; Grinsztejn, Beatriz 2021. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. The New England journal of medicine, 385 7, 595-608

O'Brien, Meagan P; Forleo-Neto, Eduardo; Musser, Bret J; Isa, Flonza; Chan, Kuo-Chen; Sarkar, Neena; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Hou, Peijie; Heirman, Ingeborg; Davis, John D; Turner, Kenneth C; Ramesh, Divya; Mahmood, Adnan; Hooper, Andrea T; Hamilton, Jennifer D; Kim, Yunji; Purcell, Lisa A; Baum, Alina; Kyratsous, Christos A; Krainson, James; Perez-Perez, Richard; Mohseni, Rizwana; Kowal, Bari; DiCioccio, A Thomas; Stahl, Neil; Lipsich, Leah; Braunstein, Ned; Herman, Gary; Yancopoulos, George D; Weinreich, David M 2021. Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. The New England journal of medicine, 385 13, 1184-1195

Presti, Rachel M; Yeh, Eunice; Williams, Brett; Landay, Alan; Jacobson, Jeffrey M; Wilson, Cara; Fichtenbaum, Carl J; Utay, Netanya S; Dube, Michael P; Klingman, Karin L; Estes, Jacob D; Flynn, Jacob K; Loftin, Amanda; Brenchley, Jason M; Andrade, Adriana; Kitch, Douglas W; Overton, Edgar T 2021. A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open forum infectious diseases, 8 12, ofab550

Zhang, Bin; Huaman, Moises A; Fichtenbaum, Carl J; Longenecker, Chris T 2021. Reply to Chu, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Boccara, Franck; Kumar, Princy N; Caramelli, Bruno; Calmy, Alexandra; López, J Antonio G; Bray, Sarah; Cyrille, Marcoli; Rosenson, Robert S 2020. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study. Journal of the American College of Cardiology, 75 20, 2570-2584

Fichtenbaum, Carl J; Ribaudo, Heather J; Leon-Cruz, Jorge; Overton, Edgar T; Zanni, Markella V; Malvestutto, Carlos D; Aberg, Judith A; Kileel, Emma M; Fitch, Kathleen V; Van Schalkwyk, Marije; Kumarasamy, Nagalingeswaran; Martinez, Esteban; Santos, Breno Riegel; Joseph, Yvetot; Lo, Janet; Siminski, Sue; Melbourne, Kathleen; Sponseller, Craig A; Desvigne-Nickens, Patrice; Bloomfield, Gerald S; Currier, Judith S; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K 2020. Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. The Journal of infectious diseases, 222 Suppl 1, S8-S19

Fitch, Kathleen V; Kileel, Emma M; Looby, Sara E; Zanni, Markella V; Sanchez, Laura R; Fichtenbaum, Carl J; Overton, Edgar T; Malvestutto, Carlos; Aberg, Judith A; Klingman, Karin L; Alston-Smith, Beverly; Lavelle, Judith; Rancourt, Anne; Badal-Faesen, Sharlaa; Cardoso, Sandra Wagner; Avihingsanon, Anchalee; Patil, Sandesh; Sponseller, Craig A; Melbourne, Kathleen; Ribaudo, Heather J; Cooper-Arnold, Katharine; Desvigne-Nickens, Patrice; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K 2020. Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination. HIV research & clinical practice, 21 1, 11-23

Gandhi, Rajesh T; Tashima, Karen T; Smeaton, Laura M; Vu, Vincent; Ritz, Justin; Andrade, Adriana; Eron, Joseph J; Hogg, Evelyn; Fichtenbaum, Carl J 2020. Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS). The Journal of infectious diseases, 221 9, 1407-1415

Huaman, Moises A; Qualls, Joseph E; Jose, Shinsmon; Schmidt, Stephanie M; Moussa, Anissa; Kuhel, David G; Konaniah, Eddy; Komaravolu, Ravi K; Fichtenbaum, Carl J; Deepe, George S; Hui, David Y 2020. Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis. Frontiers in immunology, 11 , 607957

Kozal, Michael; Aberg, Judith; Pialoux, Gilles; Cahn, Pedro; Thompson, Melanie; Molina, Jean-Michel; Grinsztejn, Beatriz; Diaz, Ricardo; Castagna, Antonella; Kumar, Princy; Latiff, Gulam; DeJesus, Edwin; Gummel, Mark; Gartland, Margaret; Pierce, Amy; Ackerman, Peter; Llamoso, Cyril; Lataillade, Max 2020. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. The New England journal of medicine, 382 13, 1232-1243

Lathouwers, Erkki; Wong, Eric Y; Brown, Kimberley; Baugh, Bryan; Ghys, Anne; Jezorwski, John; Mohsine, El Ghazi; Van Landuyt, Erika; Opsomer, Magda; De Meyer, Sandra 2020. Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials. AIDS research and human retroviruses, 36 1, 48-57

Smith, Matthew S; Bonomo, Jordan; Knight, William A; Prestigiacomo, Charles J; Richards, Christopher T; Ramser, Evan; Adeoye, Opeolu; Bertsch, Stuart; Shirani, Peyman; Vagal, Achala; Fichtenbaum, Carl J; Housholder, Anne; Khatri, Pooja; Kleindorfer, Dawn O; Broderick, Joseph P; Grossman, Aaron W 2020. Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm. Stroke, 51 6, 1902-1909

Tassiopoulos, Katherine; Roberts-Toler, Carla; Fichtenbaum, Carl J; Koletar, Susan L 2020. Web-Based Data Collection for Older Adults Living With HIV in a Clinical Research Setting: Pilot Observational Study. Journal of medical Internet research, 22 11, e18588

Beigel, John H; Aga, Evgenia; Elie-Turenne, Marie-Carmelle; Cho, Josalyn; Tebas, Pablo; Clark, Carol L; Metcalf, Jordan P; Ozment, Caroline; Raviprakash, Kanakatte; Beeler, Joy; Holley, H Preston; Warner, Stephanie; Chorley, Carla; Lane, H Clifford; Hughes, Michael D; Davey, Richard T 2019. Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial. The Lancet. Respiratory medicine, 7 11, 941-950

Eron, Joseph J; Orkin, Chloe; Cunningham, Douglas; Pulido, Federico; Post, Frank A; De Wit, Stéphane; Lathouwers, Erkki; Hufkens, Veerle; Jezorwski, John; Petrovic, Romana; Brown, Kimberley; Van Landuyt, Erika; Opsomer, Magda 2019. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1. Antiviral research, 170 , 104543

Gebhardt, Anna; Fichtenbaum, Carl J 2019. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection. Expert opinion on pharmacotherapy, 20 14, 1719-1729

Grinspoon, Steven K; Fitch, Kathleen V; Overton, Edgar Turner; Fichtenbaum, Carl J; Zanni, Markella V; Aberg, Judith A; Malvestutto, Carlos; Lu, Michael T; Currier, Judith S; Sponseller, Craig A; Waclawiw, Myron; Alston-Smith, Beverly; Cooper-Arnold, Katharine; Klingman, Karin L; Desvigne-Nickens, Patrice; Hoffmann, Udo; Ribaudo, Heather J; Douglas, Pamela S 2019. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). American heart journal, 212 , 23-35

Hoffmann, Udo; Lu, Michael T; Olalere, Devvora; Adami, Elizabeth C; Osborne, Michael T; Ivanov, Alex; Aluru, John Sukumar; Lee, Saeyun; Arifovic, Nadja; Overton, Edgar Turner; Fichtenbaum, Carl J; Aberg, Judith A; Alston-Smith, Beverly; Klingman, Karin L; Waclawiw, Myron; Burdo, Tricia H; Williams, Kenneth C; Zanni, Markella V; Desvigne-Nickens, Patrice; Cooper-Arnold, Katharine; Fitch, Kathleen V; Ribaudo, Heather; Douglas, Pamela S; Grinspoon, Steven K 2019. Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers. American heart journal, 212 , 1-12

Kalayjian, Robert C; Robertson, Kevin R; Albert, Jeffrey M; Fichtenbaum, Carl J; Brown, Todd T; Taiwo, Babafemi O 2019. Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals. Journal of acquired immune deficiency syndromes (1999), 81 2, e49-e54

Li, Jonathan Z; Sax, Paul E; Marconi, Vincent C; Fajnzylber, Jesse; Berzins, Baiba; Nyaku, Amesika N; Fichtenbaum, Carl J; Wilkin, Timothy; Benson, Constance A; Koletar, Susan L; Lorenzo-Redondo, Ramon; Taiwo, Babafemi O 2019. No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial. Open forum infectious diseases, 6 3, ofz056

Utay, Netanya S; Somasunderam, Anoma; Hinkle, John E; Petschow, Bryon W; Detzel, Christopher J; Somsouk, Ma; Fichtenbaum, Carl J; Weaver, Eric M; Shaw, Audrey L; Asmuth, David M 2019. Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART. Pathogens & immunity, 4 1, 124-146

Cahn, Pedro; Madero, Juan Sierra; Arribas, José Ramón; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E; Hung, Chien-Ching; Rockstroh, Jürgen K; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy; Currie, Alexander; Underwood, Mark; Tenorio, Allan R; Pappa, Keith; Wynne, Brian; Fettiplace, Anna; Gartland, Martin; Aboud, Michael; Smith, Kimberly 2018. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet (London, England), ,

Gianella, Sara; Marconi, Vincent C; Berzins, Baiba; Benson, Constance A; Sax, Paul; Fichtenbaum, Carl J; Wilkin, Timothy; Vargas, Millie; Deng, Qianqian; Oliveira, Michelli F; Moser, Carlee; Taiwo, Babafemi O 2018. Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. Journal of acquired immune deficiency syndromes (1999), 79 5, e112-e114

Hsue, Priscilla Y; Ribaudo, Heather J; Deeks, Steven G; Bell, Tanvir; Ridker, Paul M; Fichtenbaum, Carl; Daar, Eric S; Havlir, Diane; Yeh, Eunice; Tawakol, Ahmed; Lederman, Michael; Currier, Judith S; Stein, James H 2018. Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Huaman, Moises A; Henson, David; Rondan, Paola L; Ticona, Eduardo; Miranda, Gustavo; Kryscio, Richard J; Mugruza, Raquel; Aranda, Ernesto; Ticona, Cesar; Abarca, Susan; Heredia, Paula; Aguirre, Andres; Sterling, Timothy R; Garvy, Beth A; Fichtenbaum, Carl J 2018. Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru. PloS one, 13 9, e0202191

Huaman, Moises A; Ticona, Eduardo; Miranda, Gustavo; Kryscio, Richard J; Mugruza, Raquel; Aranda, Ernesto; Rondan, Paola L; Henson, David; Ticona, Cesar; Sterling, Timothy R; Fichtenbaum, Carl J; Garvy, Beth A 2018. The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66 6, 886-892

Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge; Gupta, Samir K; McComsey, Grace A; Klingman, Karin L; Fichtenbaum, Carl J; Brown, Todd T; Taiwo, Babafemi O 2018. Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS (London, England), 32 17, 2517-2524

Orkin, Chloe; Molina, Jean-Michel; Negredo, Eugenia; Arribas, José R; Gathe, Joseph; Eron, Joseph J; Van Landuyt, Erika; Lathouwers, Erkki; Hufkens, Veerle; Petrovic, Romana; Vanveggel, Simon; Opsomer, Magda 2018. Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial. The lancet. HIV, 5 1, e23-e34

Rai, Mohammad A; Pannek, Sam; Fichtenbaum, Carl J 2018. Emerging reverse transcriptase inhibitors for HIV-1 infection. Expert opinion on emerging drugs, 23 2, 149-157

Shive, Carey L; Judge, Chelsey J; Clagett, Brian; Kalayjian, Robert C; Osborn, Melissa; Sherman, Kenneth E; Fichtenbaum, Carl; Gandhi, Rajesh T; Kang, Minhee; Popkin, Daniel L; Sieg, Scott F; Lederman, Michael M; Rodriguez, Benigno; Anthony, Donald D 2018. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine, 36 4, 453-460

Taiwo, Babafemi O; Marconi, Vincent C; Berzins, Baiba; Moser, Carlee B; Nyaku, Amesika N; Fichtenbaum, Carl J; Benson, Constance A; Wilkin, Timothy; Koletar, Susan L; Colasanti, Jonathan; Acosta, Edward P; Li, Jonathan Z; Sax, Paul E 2018. Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66 11, 1794-1797

Utay, Netanya S; Kitch, Douglas W; Yeh, Eunice; Fichtenbaum, Carl J; Lederman, Michael M; Estes, Jacob D; Deleage, Claire; Magyar, Clara; Nelson, Scott D; Klingman, Karen L; Bastow, Barbara; Luque, Amneris E; McComsey, Grace A; Douek, Daniel C; Currier, Judith S; Lake, Jordan E 2018. Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone. The Journal of infectious diseases, 217 11, 1770-1781

Cahn, Pedro; Kaplan, Richard; Sax, Paul E; Squires, Kathleen; Molina, Jean-Michel; Avihingsanon, Anchalee; Ratanasuwan, Winai; Rojas, Evelyn; Rassool, Mohammed; Bloch, Mark; Vandekerckhove, Linos; Ruane, Peter; Yazdanpanah, Yazdan; Katlama, Christine; Xu, Xia; Rodgers, Anthony; East, Lilly; Wenning, Larissa; Rawlins, Sandy; Homony, Brenda; Sklar, Peter; Nguyen, Bach-Yen; Leavitt, Randi; Teppler, Hedy 2017. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. The lancet. HIV, 4 11, e486-e494

Huaman, M A; Kryscio, R J; Fichtenbaum, C J; Henson, D; Salt, E; Sterling, T R; Garvy, B A 2017. Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysis. Epidemiology and infection, 145 7, 1363-1367

Rentz, Michael F; Ruffner, Andrew H; Ancona, Rachel M; Hart, Kimberly W; Kues, John R; Barczak, Christopher M; Lindsell, Christopher J; Fichtenbaum, Carl J; Lyons, Michael S 2017. Pilot Integration of HIV Screening and Healthcare Settings with Multi- Component Social Network and Partner Testing for HIV Detection. Current HIV research, 15 5, 372-381

Chan, Ellen S; Landay, Alan L; Brown, Todd T; Ribaudo, Heather J; Mirmonsef, Paria; Ofotokun, Igho; Weitzmann, M Neale; Martinson, Jeffrey; Klingman, Karin L; Eron, Joseph J; Fichtenbaum, Carl J; Plants, Jill; Taiwo, Babafemi O 2016. Differential CD4+ cell count increase and CD4+?: ?CD8+ ratio normalization with maraviroc compared with tenofovir. AIDS (London, England), 30 13, 2091-7

Jacobson, Jeffrey M; Zheng, Lu; Wilson, Cara C; Tebas, Pablo; Matining, Roy M; Egan, Michael A; Eldridge, John; Landay, Alan L; Clifford, David B; Luetkemeyer, Anne F; Tiu, Jennifer; Martinez, Ana L; Janik, Jennifer; Spitz, Teresa A; Hural, John; McElrath, Juliana; Frahm, Nicole 2016. The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. Journal of acquired immune deficiency syndromes (1999), 71 2, 163-71

Lyons, Michael S; Kunnathur, Vidhya A; Rouster, Susan D; Hart, Kimberly W; Sperling, Matthew I; Fichtenbaum, Carl J; Sherman, Kenneth E 2016. Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62 9, 1066-71

Stellbrink, Hans-Jürgen; Le Fevre, Eric; Carr, Andrew; Saag, Michael S; Mukwaya, Geoffrey; Nozza, Silvia; Valluri, Srinivas Rao; Vourvahis, Manoli; Rinehart, Alex R; McFadyen, Lynn; Fichtenbaum, Carl; Clark, Andrew; Craig, Charles; Fang, Annie F; Heera, Jayvant 2016. Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment. AIDS (London, England), 30 8, 1229-38

Dubé, Michael P; Komarow, Lauren; Fichtenbaum, Carl J; Cadden, Joseph J; Overton, Edgar T; Hodis, Howard N; Currier, Judith S; Stein, James H 2015. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 61 5, 840-9

Longenecker, Chris T; Kitch, Douglas; Sax, Paul E; Daar, Eric S; Tierney, Camlin; Gupta, Samir K; McComsey, Grace A 2015. Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s. Journal of acquired immune deficiency syndromes (1999), 69 2, 168-77

Taiwo, Babafemi O; Chan, Ellen S; Fichtenbaum, Carl J; Ribaudo, Heather; Tsibris, Athe; Klingman, Karin L; Eron, Joseph J; Berzins, Baiba; Robertson, Kevin; Landay, Alan; Ofotokun, Igho; Brown, Todd 2015. Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 61 7, 1179-88

Tashima, Karen T; Mollan, Katie R; Na, Lumine; Gandhi, Rajesh T; Klingman, Karin L; Fichtenbaum, Carl J; Andrade, Adriana; Johnson, Victoria A; Eron, Joseph J; Smeaton, Laura; Haubrich, Richard H 2015. Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity. HIV clinical trials, 16 4, 147-56

Tashima, Karen T; Smeaton, Laura M; Fichtenbaum, Carl J; Andrade, Adriana; Eron, Joseph J; Gandhi, Rajesh T; Johnson, Victoria A; Klingman, Karin L; Ritz, Justin; Hodder, Sally; Santana, Jorge L; Wilkin, Timothy; Haubrich, Richard H 2015. HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial. Annals of internal medicine, 163 12, 908-17

Lennox, J L; Landovitz, R J; Ribaudo, H J; Ofotokun, I; Na, L H; Godfrey, C; Kuritzkes, D R; Sagar, M; Brown, T T; Cohn, S E; McComsey, G A; Aweeka, F; Fichtenbaum, C J; Presti, R M; Koletar, S L; Haas, D W; Patterson, K B; Benson, C A; Baugh, B P; Leavitt, R Y; Rooney, J F; Seekins, D; Currier, J S 2014. Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1. Annals of internal medicine, 161 7, I-22

Lennox, Jeffrey L; Landovitz, Raphael J; Ribaudo, Heather J; Ofotokun, Ighovwerha; Na, Lumine H; Godfrey, Catherine; Kuritzkes, Daniel R; Sagar, Manish; Brown, Todd T; Cohn, Susan E; McComsey, Grace A; Aweeka, Francesca; Fichtenbaum, Carl J; Presti, Rachel M; Koletar, Susan L; Haas, David W; Patterson, Kristine B; Benson, Constance A; Baugh, Bryan P; Leavitt, Randi Y; Rooney, James F; Seekins, Daniel; Currier, Judith S 2014. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Annals of internal medicine, 161 7, 461-71

Moschella, Phillip C; Hart, Kimberly W; Ruffner, Andrew H; Lindsell, Christopher J; Wayne, D Beth; Sperling, Matthew I; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S 2014. Prevalence of undiagnosed acute and chronic HIV in a lower-prevalence urban emergency department. American journal of public health, 104 9, 1695-9

Sandler, Netanya G; Zhang, Xinyan; Bosch, Ronald J; Funderburg, Nicholas T; Choi, Andrew I; Robinson, Janet K; Fine, Derek M; Coombs, Robert W; Jacobson, Jeffrey M; Landay, Alan L; Douek, Daniel C; Tressler, Randall; Read, Sarah W; Wilson, Cara C; Deeks, Steven G; Lederman, Michael M; Gandhi, Rajesh T 2014. Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection. The Journal of infectious diseases, 210 10, 1549-54

Warm, Eric J; Mathis, Bradley R; Held, Justin D; Pai, Savita; Tolentino, Jonathan; Ashbrook, Lauren; Lee, Cheryl K; Lee, David; Wood, Sharice; Fichtenbaum, Carl J; Schauer, Daniel; Munyon, Ryan; Mueller, Caroline 2014. Entrustment and Mapping of Observable Practice Activities for Resident Assessment. Journal of general internal medicine, ,

Lyons, Michael S; Lindsell, Christopher J; Ruffner, Andrew H; Wayne, D Beth; Hart, Kimberly W; Sperling, Matthew I; Trott, Alexander T; Fichtenbaum, Carl J 2013. Randomized Comparison of Universal and Targeted HIV Screening in the Emergency Department. Journal of acquired immune deficiency syndromes (1999), ,

McComsey, Grace A; Daar, Eric S; O'Riordan, MaryAnn; Collier, Ann C; Kosmiski, Lisa; Santana, Jorge L; Fichtenbaum, Carl J; Fink, Heidi; Sax, Paul E; Libutti, Daniel E; Gerschenson, Mariana 2013. Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202. The Journal of infectious diseases, 207 4, 604-11

Wohl, David A; Arnoczy, Gretchen; Fichtenbaum, Carl J; Campbell, Thomas; Taiwo, Babafemi; Hicks, Charles; McComsey, Grace A; Koletar, Susan; Sax, Paul; Tebas, Pablo; Ha, Belinda; Massengale, Kelly; Walsh, Kendall; Stein, James H 2013. Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antiviral therapy, ,

Presicce, Pietro; Moreno-Fernandez, Maria E; Rusie, Laura K; Fichtenbaum, Carl; Chougnet, Claire A 2012. In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells. PloS one, 7 8, e42802

Samineni, Divya; Desai, Pankaj B; Sallans, Larry; Fichtenbaum, Carl J 2012. Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin. Journal of clinical pharmacology, 52 6, 922-31

Brehm, Jessica H; Lalama, Christina M; Hughes, Michael D; Haubrich, Richard; Riddler, Sharon A; Sluis-Cremer, Nicolas; Mellors, John W 2011. Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. Journal of acquired immune deficiency syndromes (1999), 56 4, 344-8

Fichtenbaum, Carl J 2011. Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. Current infectious disease reports, 13 1, 94-101

Fichtenbaum, Carl J; Evans, Scott E; Aberg, Judith A 2011. High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection. AIDS (London, England), 25 16, 2053

Hudepohl, Nathan J; Lindsell, Christopher J; Hart, Kimberly W; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S 2011. Effect of an emergency department HIV testing program on the proportion of emergency department patients who have been tested. Annals of emergency medicine, 58 1 Suppl 1, S140-4

Lyons, Michael S; Lindsell, Christopher J; Wayne, D Beth; Ruffner, Andrew H; Hart, Kimberly W; Fichtenbaum, Carl J; Trott, Alexander T; Sullivan, Patrick S 2011. Comparison of missed opportunities for earlier HIV diagnosis in 3 geographically proximate emergency departments. Annals of emergency medicine, 58 1 Suppl 1, S17-22.e1

Nyakeriga, Alice M; Ying, Jun; Shire, Norah J; Fichtenbaum, Carl J; Chougnet, Claire A 2011. Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo. Viral immunology, 24 4, 281-9

Presicce, Pietro; Orsborn, Kris; King, Eileen; Pratt, Jesse; Fichtenbaum, Carl J; Chougnet, Claire A 2011. Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PloS one, 6 12, e28118

Sax, Paul E; Tierney, Camlin; Collier, Ann C; Daar, Eric S; Mollan, Katie; Budhathoki, Chakra; Godfrey, Catherine; Jahed, Nasreen C; Myers, Laurie; Katzenstein, David; Farajallah, Awny; Rooney, James F; Ha, Belinda; Woodward, William C; Feinberg, Judith; Tashima, Karen; Murphy, Robert L; Fischl, Margaret A 2011. Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. The Journal of infectious diseases, 204 8, 1191-201

Sitlinger, Andrea P; Lindsell, Christopher J; Ruffner, Andrew H; Wayne, D Beth; Hart, Kimberly W; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S 2011. Preliminary program evaluation of emergency department HIV prevention counseling. Annals of emergency medicine, 58 1 Suppl 1, S120-5.e1-3

Taiwo, Babafemi; Zheng, Lu; Gallien, Sebastien; Matining, Roy M; Kuritzkes, Daniel R; Wilson, Cara C; Berzins, Baiba I; Acosta, Edward P; Bastow, Barbara; Kim, Peter S; Eron, Joseph J 2011. Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262). AIDS (London, England), 25 17, 2113-22

Ubhayakar, Nitin D; Lindsell, Christopher J; Raab, Dana L; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S 2011. Risk, reasons for refusal, and impact of counseling on consent among ED patients declining HIV screening. The American journal of emergency medicine, 29 4, 367-72

Fichtenbaum, Carl J 2010. Does antiretroviral therapy increase or decrease the risk of cardiovascular disease? Current HIV/AIDS reports, 7 2, 92-8

Flexner, Charles; Tierney, Camlin; Gross, Robert; Andrade, Adriana; Lalama, Christina; Eshleman, Susan H; Aberg, Judith; Sanne, Ian; Parsons, Teresa; Kashuba, Angela; Rosenkranz, Susan L; Kmack, Anne; Ferguson, Elaine; Dehlinger, Marjorie; Mildvan, Donna 2010. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 50 7, 1041-52

Jacobson, Jeffrey M; Lalezari, Jacob P; Thompson, Melanie A; Fichtenbaum, Carl J; Saag, Michael S; Zingman, Barry S; D'Ambrosio, Paul; Stambler, Nancy; Rotshteyn, Yakov; Marozsan, Andre J; Maddon, Paul J; Morris, Stephen A; Olson, William C 2010. Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-infected Adults. Antimicrobial agents and chemotherapy, ,

McComsey, Grace A; Walker, Ulrich A; Budhathoki, Chakra B; Su, Zhaohui; Currier, Judith S; Kosmiski, Lisa; Naini, Linda G; Charles, Stéphannie; Medvik, Kathy; Aberg, Judith A 2010. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS (London, England), 24 16, 2507-15

Murphy, Robert L; Berzins, Baiba; Zala, Carlos; Fichtenbaum, Carl; Dube, Michael P; Guaraldi, Giovanni; Torriani, Francesca; Belsey, Elizabeth; Mitchell, Carol; Stein, James H 2010. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy. AIDS (London, England), 24 6, 885-90

Samineni, Divya; Fichtenbaum, Carl J 2010. Fenofibrate in the treatment of dyslipidemia associated with HIV infection. Expert opinion on drug metabolism & toxicology, 6 8, 995-1004

Fichtenbaum, Carl J 2009. Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Current infectious disease reports, 11 1, 84-92

Gross, Robert; Tierney, Camlin; Andrade, Adriana; Lalama, Christina; Rosenkranz, Susan; Eshleman, Susan H; Flanigan, Timothy; Santana, Jorge; Salomon, Nadim; Reisler, Ronald; Wiggins, Ilene; Hogg, Evelyn; Flexner, Charles; Mildvan, Donna 2009. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Archives of internal medicine, 169 13, 1224-32

Haubrich, Richard H; Riddler, Sharon A; DiRienzo, A Gregory; Komarow, Lauren; Powderly, William G; Klingman, Karin; Garren, Kevin W; Butcher, David L; Rooney, James F; Haas, David W; Mellors, John W; Havlir, Diane V 2009. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS (London, England), 23 9, 1109-18

Lyons, Michael S; Lindsell, Christopher J; Raab, Dana L; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J 2009. Comparison of emergency department HIV testing data with visit or patient as the unit of analysis. Journal of medical screening, 16 1, 29-32

Lyons, Michael S; Lindsell, Christopher J; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J 2009. Relationship of self-reported prior testing history to undiagnosed HIV positivity and HIV risk. Current HIV research, 7 6, 580-8

Nyakeriga, Alice M; Fichtenbaum, Carl J; Goebel, Jens; Nicolaou, Stella A; Conforti, Laura; Chougnet, Claire A 2009. Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection. Journal of virology, 83 3, 1193-200

Dubé, Michael P; Lipshultz, Steven E; Fichtenbaum, Carl J; Greenberg, Richard; Schecter, Alison D; Fisher, Stacy D 2008. Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation, 118 2, e36-40

Fichtenbaum, Carl J 2008. Editorial comment: the head bone is connected to the body bone. The AIDS reader, 18 5, 265

Gerber, John G; Kitch, Douglas W; Fichtenbaum, Carl J; Zackin, Robert A; Charles, Stéphannie; Hogg, Evelyn; Acosta, Edward P; Connick, Elizabeth; Wohl, David; Kojic, E Milu; Benson, Constance A; Aberg, Judith A 2008. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. Journal of acquired immune deficiency syndromes (1999), 47 4, 459-66

Jacobson, Jeffrey M; Saag, Michael S; Thompson, Melanie A; Fischl, Margaret A; Liporace, Ralph; Reichman, Richard C; Redfield, Robert R; Fichtenbaum, Carl J; Zingman, Barry S; Patel, Mahesh C; Murga, Jose D; Pemrick, Suzanne M; D'Ambrosio, Paul; Michael, Marti; Kroger, Hans; Ly, Hieu; Rotshteyn, Yakov; Buice, Robert; Morris, Stephen A; Stavola, Joseph J; Maddon, Paul J; Kremer, Alton B; Olson, William C 2008. Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults. The Journal of infectious diseases, 198 9, 1345-52

Lyons, Michael S; Lindsell, Christopher J; R N, Deanna A Hawkins; Rn, Dana L Raab; Trott, Alexander T; Fichtenbaum, Carl J 2008. Contributions to early HIV diagnosis among patients linked to care vary by testing venue. BMC public health, 8 , 220

Riddler, Sharon A; Haubrich, Richard; DiRienzo, A Gregory; Peeples, Lynne; Powderly, William G; Klingman, Karin L; Garren, Kevin W; George, Tania; Rooney, James F; Brizz, Barbara; Lalloo, Umesh G; Murphy, Robert L; Swindells, Susan; Havlir, Diane; Mellors, John W 2008. Class-sparing regimens for initial treatment of HIV-1 infection. The New England journal of medicine, 358 20, 2095-106

Stein, James H; Komarow, Lauren; Cotter, Bruno R; Currier, Judith S; Dubé, Michael P; Fichtenbaum, Carl J; Gerschenson, Mariana; Mitchell, Carol K C; Murphy, Robert L; Squires, Kathleen; Parker, Robert A; Torriani, Francesca J 2008. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. Journal of clinical lipidology, 2 6, 464-471

Torriani, Francesca J; Komarow, Lauren; Parker, Robert A; Cotter, Bruno R; Currier, Judith S; Dubé, Michael P; Fichtenbaum, Carl J; Gerschenson, Mariana; Mitchell, Carol K C; Murphy, Robert L; Squires, Kathleen; Stein, James H 2008. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. Journal of the American College of Cardiology, 52 7, 569-76

Vazquez, José A; Schranz, Jennifer A; Clark, Kay; Goldstein, Beth P; Reboli, Annette; Fichtenbaum, Carl 2008. A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis. Journal of acquired immune deficiency syndromes (1999), 48 3, 304-9

Velilla, P A; Shata, M T; Lages, C S; Ying, J; Fichtenbaum, C J; Chougnet, C 2008. Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients. AIDS research and human retroviruses, 24 1, 52-61

de Perio, Marie A; Gomez, Francisco J; Frame, Peter T; Fichtenbaum, Carl J 2007. A truvada hypersensitivity reaction simulating abacavir hypersensitivity. AIDS (London, England), 21 16, 2252-3

Huang, I; Leach, J L; Fichtenbaum, C J; Narayan, R K 2007. Osteomyelitis of the skull in early-acquired syphilis: evaluation by MR imaging and CT. AJNR. American journal of neuroradiology, 28 2, 307-8

Lyons, Michael S; Raab, Dana L; Lindsell, Christopher J; Trott, Alexander T; Fichtenbaum, Carl J 2007. A novel emergency department based prevention intervention program for people living with HIV: evaluation of early experiences. BMC health services research, 7 , 164

Shire, Norah J; Rouster, Susan D; Stanford, Sandra D; Blackard, Jason T; Martin, Christina M; Fichtenbaum, Carl J; Sherman, Kenneth E 2007. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 44 3, 309-14

Aberg, Judith A; Rosenkranz, Susan L; Fichtenbaum, Carl J; Alston, Beverly L; Brobst, Susan W; Segal, Yoninah; Gerber, John G 2006. Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108. AIDS (London, England), 20 5, 725-9

Robertson, Jaime; Meier, Matthew; Wall, Jennifer; Ying, Jun; Fichtenbaum, Carl J 2006. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 11, 1639-46

Wohl, D A; McComsey, G; Tebas, P; Brown, T T; Glesby, M J; Reeds, D; Shikuma, C; Mulligan, K; Dube, M; Wininger, D; Huang, J; Revuelta, M; Currier, J; Swindells, S; Fichtenbaum, C; Basar, M; Tungsiripat, M; Meyer, W; Weihe, J; Wanke, C 2006. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 43 5, 645-53

Aberg, Judith A; Zackin, Robert A; Brobst, Susan W; Evans, Scott R; Alston, Beverly L; Henry, W Keith; Glesby, Marshall J; Torriani, Francesca J; Yang, Yijun; Owens, Susan I; Fichtenbaum, Carl J 2005. A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. AIDS research and human retroviruses, 21 9, 757-67

Fichtenbaum, Carl J; Hadigan, Colleen M; Kotler, Donald P; Pierone, Gerald; Sax, Paul E; Steinhart, Corklin R; Tebas, Pablo 2005. Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care. IAPAC monthly, 11 2, 38-46

Gerber, John G; Rosenkranz, Susan L; Fichtenbaum, Carl J; Vega, Jose M; Yang, Amy; Alston, Beverly L; Brobst, Susan W; Segal, Yoninah; Aberg, Judith A 2005. Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. Journal of acquired immune deficiency syndromes (1999), 39 3, 307-12

Glesby, Marshall J; Aberg, Judith A; Kendall, Michelle A; Fichtenbaum, Carl J; Hafner, Richard; Hall, Stephen; Grosskopf, Nicole; Zolopa, Andrew R; Gerber, John G 2005. Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. Clinical pharmacology and therapeutics, 78 2, 143-53

Glesby, Marshall J; Bassett, Roland; Alston-Smith, Beverly; Fichtenbaum, Carl; Jacobson, Elizabeth L; Brass, Clifford; Owens, Susan; Sulkowski, Mark; Race, Elizabeth M; Sherman, Kenneth E 2005. Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. The Journal of infectious diseases, 191 5, 686-93

Goldman, Mitchell; Cloud, Gretchen A; Wade, Karen D; Reboli, Annette C; Fichtenbaum, Carl J; Hafner, Richard; Sobel, Jack D; Powderly, William G; Patterson, Thomas F; Wheat, Lawrence J; Stein, David K; Dismukes, William E; Filler, Scott G 2005. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 10, 1473-80

Acosta, Edward P; Wu, Hulin; Hammer, Scott M; Yu, Song; Kuritzkes, Daniel R; Walawander, Ann; Eron, Joseph J; Fichtenbaum, Carl J; Pettinelli, Carla; Neath, Denise; Ferguson, Elaine; Saah, Alfred J; Gerber, John G 2004. Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals. Journal of acquired immune deficiency syndromes (1999), 37 3, 1358-66

Goldman, Mitchell; Zackin, Robert; Fichtenbaum, Carl J; Skiest, Daniel J; Koletar, Susan L; Hafner, Richard; Wheat, L Joseph; Nyangweso, Peter M; Yiannoutsos, Constantin T; Schnizlein-Bick, Carol T; Owens, Susan; Aberg, Judith A 2004. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38 10, 1485-9

Zhang, Rui; Fichtenbaum, Carl J; Hildeman, David A; Lifson, Jeffrey D; Chougnet, Claire 2004. CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription. Journal of immunology (Baltimore, Md. : 1950), 172 4, 2678-86

Dubé, Michael P; Stein, James H; Aberg, Judith A; Fichtenbaum, Carl J; Gerber, John G; Tashima, Karen T; Henry, W Keith; Currier, Judith S; Sprecher, Dennis; Glesby, Marshall J 2003. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37 5, 613-27

Fichtenbaum, Carl J 2003. Antiretrovirals and cardiovascular disease: is HAART bad for your heart? AIDS clinical care, 15 8, 69-73, 76

Landon, Bruce E; Wilson, Ira B; Cohn, Susan E; Fichtenbaum, Carl J; Wong, Mitchell D; Wenger, Neil S; Bozzette, Samuel A; Shapiro, Martin F; Cleary, Paul D 2003. Physician specialization and antiretroviral therapy for HIV. Journal of general internal medicine, 18 4, 233-41

Riddle, Tara M; Fichtenbaum, Carl J; Hui, David Y 2003. Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice. Journal of acquired immune deficiency syndromes (1999), 33 5, 564-70

Daly, Kieran R; Fichtenbaum, Carl J; Tanaka, Reiko; Linke, Michael J; O'Bert, Robert; Thullen, Timothy D; Hui, Michele S; Smulian, Alan G; Walzer, Peter D 2002. Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons. The Journal of infectious diseases, 186 5, 644-51

David, Max H; Hornung, Richard; Fichtenbaum, Carl J 2002. Ischemic cardiovascular disease in persons with human immunodeficiency virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 1, 98-102

Fichtenbaum, Carl J; Gerber, John G 2002. Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection. Clinical pharmacokinetics, 41 14, 1195-211

Fichtenbaum, Carl J; Gerber, John G; Rosenkranz, Susan L; Segal, Yoninah; Aberg, Judith A; Blaschke, Terrence; Alston, Beverly; Fang, Fang; Kosel, Bradley; Aweeka, Francesca 2002. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. AIDS (London, England), 16 4, 569-77

Landon, Bruce E; Wilson, Ira B; Wenger, Neil S; Cohn, Susan E; Fichtenbaum, Carl J; Bozzette, Samuel A; Shapiro, Martin F; Cleary, Paul D 2002. Specialty training and specialization among physicians who treat HIV/AIDS in the United States. Journal of general internal medicine, 17 1, 12-22

Levine, Nicholas B; Kurokawa, Ryu; Fichtenbaum, Carl J; Howington, John A; Kuntz, Charles 2002. An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis. Journal of spinal disorders & techniques, 15 5, 425-30

Riddle, Tara M; Schildmeyer, Nicholas M; Phan, Cam; Fichtenbaum, Carl J; Hui, David Y 2002. The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice. Journal of lipid research, 43 9, 1458-63

Currier, J S; Williams, P; Feinberg, J; Becker, S; Owens, S; Fichtenbaum, C; Benson, C 2001. Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32 11, 1615-22

Fichtenbaum, C J 2001. The evaluation and management of dyslipidemia in HIV-infected patients. AIDS clinical care, 13 12, 113-7, 120

Fichtenbaum, C J; Zackin, R; Feinberg, J 2001. Reply to 'Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis' by Holmberg and Moorman. AIDS (London, England), 15 13, 1745

Riddle, T M; Kuhel, D G; Woollett, L A; Fichtenbaum, C J; Hui, D Y 2001. HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. The Journal of biological chemistry, 276 40, 37514-9

Riddle, T M; Kuhel, D G; Woollett, L A; Fichtenbaum, C J; Hui, D Y 2001. HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. The Journal of biological chemistry, 276 40, 37514-9

Soloway, B; Fichtenbaum, C J 2001. One size does not fit all. AIDS clinical care, 13 10, 92-3

Tantisiriwat, W; Tebas, P; Polish, L B; Casabar, E; Powderly, W G; Fichtenbaum, C J 2001. Elevated lactate levels in hospitalized persons with HIV infection. AIDS research and human retroviruses, 17 3, 195-201

Fichtenbaum, C J; Koletar, S; Yiannoutsos, C; Holland, F; Pottage, J; Cohn, S E; Walawander, A; Frame, P; Feinberg, J; Saag, M; Van der Horst, C; Powderly, W G 2000. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 5, 749-56

Fichtenbaum, C J; Zackin, R; Feinberg, J; Benson, C; Griffiths, J K 2000. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS (London, England), 14 18, 2889-93

Fichtenbaum, C J; Zackin, R; Rajicic, N; Powderly, W G; Wheat, L J; Zingman, B S 2000. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295. AIDS (London, England), 14 7, 845-52

Taylor, B N; Fichtenbaum, C; Saavedra, M; Slavinsky III, J; Swoboda, R; Wozniak, K; Arribas, A; Powderly, W; Fidel Jr, P L 2000. In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. The Journal of infectious diseases, 182 3, 955-9

Fichtenbaum, C J; German, M; Dunagan, W C; Fraser, V J; Medoff, G; Diego, J; Powderly, W G 1999. A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 29 6, 1551-6

Tantisiriwat, W; Tebas, P; Clifford, D B; Powderly, W G; Fichtenbaum, C J 1999. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 28 5, 1152-4

Cottler, L B; Compton, W M; Ben Abdallah, A; Cunningham-Williams, R; Abram, F; Fichtenbaum, C; Dotson, W 1998. Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public health reports (Washington, D.C. : 1974), 113 Suppl 1 , 31-41

Fichtenbaum, C J 1998. I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections. Research initiative, treatment action : RITA, 4 4, 3-7

Fichtenbaum, C J; Powderly, W G 1998. Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 26 3, 556-65

Seydel, K B; Zhang, T; Champion, G A; Fichtenbaum, C; Swanson, P E; Tzipori, S; Griffiths, J K; Stanley, S L 1998. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infection and immunity, 66 5, 2379-82

Widmer, G; Tzipori, S; Fichtenbaum, C J; Griffiths, J K 1998. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. The Journal of infectious diseases, 178 3, 834-40

Wu, A W; Jacobson, D L; Berzon, R A; Revicki, D A; van der Horst, C; Fichtenbaum, C J; Saag, M S; Lynn, L; Hardy, D; Feinberg, J 1997. The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 6 1, 3-10

Arribas, J R; Clifford, D B; Fichtenbaum, C J; Commins, D L; Powderly, W G; Storch, G A 1995. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. The Journal of infectious diseases, 172 2, 527-31

Arribas, J R; Clifford, D B; Fichtenbaum, C J; Roberts, R L; Powderly, W G; Storch, G A 1995. Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. Journal of clinical microbiology, 33 6, 1580-3

Fichtenbaum, C J; Clifford, D B; Powderly, W G 1995. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 10 2, 169-74

Fichtenbaum, C J; Dunagan, W C; Powderly, W G 1995. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 8 1, 51-7

Fichtenbaum, C J; Woeltje, K F; Powderly, W G 1994. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 19 3, 417-22

Fichtenbaum, C J; Peterson, L R; Weil, G J 1993. Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. The American journal of medicine, 95 4, 351-7

Fichtenbaum, C J; Ritchie, D J; Powderly, W G 1993. Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 16 2, 298-300

Fichtenbaum, C J; Smith, M J 1992. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 14 1, 353-4

Afridi, S A; Fichtenbaum, C J; Taubin, H 1991. Review of duodenal diverticula. The American journal of gastroenterology, 86 8, 935-8

Fichtenbaum, C J; Kleinman, G M; Haddad, R G 1990. Eosinophilic granuloma of the lung presenting as a solitary pulmonary nodule. Thorax, 45 11, 905-6

Fichtenbaum, C J; Babb, J D; Baker, D A 1988. Erythromycin induced cardiovascular toxicity. Connecticut medicine, 52 3, 135-6

Asmuth, David M; Hinkle, John E; LaMarca, Anthony; Fichtenbaum, Carl J; Somsouk, Ma; Utay, Netanya S; Shaw, Audrey L; Petschow, Bryon W; Detzel, Christopher J; Weaver, Eric M . Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea. HIV clinical trials, 18 5-6, 205-213

Eckman, Mark H; Powers-Fletcher, Margaret V; Forrester, Jennifer W; Fichtenbaum, Carl J; Lofgren, Richard; Smulian, Alan George . Take Your Best Shot: Which SARS-CoV-2 Vaccine Should I Get? MDM policy & practice, 6 2, 23814683211031226

Evans, Scott R; Fichtenbaum, Carl J; Aberg, Judith A . Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087. HIV clinical trials, 8 1, 45-52

Fichtenbaum, Carl J . Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons. HIV clinical trials, 5 6, 416-33

Fichtenbaum, Carl J; Yeh, Tzu-Min; Evans, Scott R; Aberg, Judith A . Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087. Journal of clinical lipidology, 4 4, 279-87

Grandominico, Jodi M; Fichtenbaum, Carl J . Short-term effect of HAART on blood pressure in HIV-infected individuals. HIV clinical trials, 9 1, 52-60

Huaman, Moises A; Deepe, George S; Fichtenbaum, Carl J . Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection. Pathogens & immunity, 1 2, 291-303

Lyons, Michael S; Lindsell, Christopher J; Fichtenbaum, Carl J; Camargo, Carlos A . Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings. Public health reports (Washington, D.C. : 1974), 122 5, 579-83

Mohajer, Mayar Al; Lyons, Michael; King, Eileen; Pratt, Jesse; Fichtenbaum, Carl J . Internal Medicine and Emergency Medicine Physicians Lack Accurate Knowledge of Current CDC HIV Testing Recommendations and Infrequently Offer HIV Testing. Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 11 2, 101-8

Monteferrante, M L; Shimkin, P M; Fichtenbaum, C; Kleinman, G M; Lipow, K I . Tentorial traversal by ependymoblastoma. AJNR. American journal of neuroradiology, 12 1, 181

Perazzo, Joseph D; Webel, Allison R; Fichtenbaum, Carl J; McComsey, Grace A . Bone Health in People Living With HIV: The Role of Exercise and Directions for Future Research. The Journal of the Association of Nurses in AIDS Care : JANAC, 29 2, 330-337